The Longevity Dividend
Source details
- Canonical URL
- The Longevity Dividend
Other formats
Bibliographic details
- Authors: ANDREW SCOTT, PETER PIOT
- Published: June 2, 2025
Overview
- The familiar narrative: declining birth rates and longer lifespans will shrink populations and raise pension and eldercare costs, leaving relatively fewer workers to fund them.
- Key contextual facts:
- "One in ten people worldwide are now over 65, and that proportion is projected to double over the next 50 years."
- Population decline has begun in places such as Japan and China; these countries and Europe are experiencing a sharp increase in median age.
- In Europe, "90 percent of the increase in workers in the past decade—17 million more people in employment—came from a jump in workers over 50." In Japan, the proportion is even higher.
Adapting to longevity
- Core reframing:
- Stop viewing aging only as a problem; longer, healthier lives are a major achievement and an opportunity.
- Shift policy focus from trying to preserve existing systems through individual behavior change to helping each person adapt to greater life expectancy.
- Implications:
- Global life expectancy is "now exceeding 70, and even 80 in an increasing number of countries."
- Traditional health, education, work, and financial systems—designed for 20th-century life expectancies—are inadequate for more people living from 60 to 90.
- Policies that change age structure (higher birth rates, immigration) delay but do not solve the deeper challenge of adjusting systems to longer lives.
- Recommendation:
- "Investing in the human and social capital of our later years is the only sustainable solution to the challenges of an aging society."
Expansion of morbidity
- Epidemiological shift:
- Chronic noncommunicable diseases now account for "60 percent of the disease burden globally, and 81 percent in the European Union."
- Healthy life expectancy has not grown as fast as overall life expectancy, producing an "expansion of morbidity."
- Prevention rationale and enablers:
- Increased longevity means most people can expect to experience chronic disease.
- Greater availability of structural risk and genetic data enables targeted interventions.
- Advances in biology offer preventive prospects; example therapeutics: "GLP-1 drugs such as Ozempic and Wegovy."
- Investments in life sciences and biopharmaceuticals could deliver improved vaccines for older people, cancer therapies, synthetic biology, and genomics.
Life-course approach
- Strategic shifts:
- Aim for a healthy 90-year-old by starting prevention in childhood—and no later than middle age.
- Prioritize measures of healthy life expectancy when allocating health expenditure rather than focusing on treating disease and operations.
- Financing and innovation:
- Prevention requires additional spending; options include more government debt or "innovative financing, such as social impact bonds that support increased health expenditure today funded by future gains."
- Technological solutions: robotics (as in Japan) for care; digital innovation and artificial intelligence for personalized prevention—contingent on investing in digital literacy across ages and social strata.
- Cross-sector actions:
- Tackle socioeconomic determinants of health via involvement of businesses, all levels of government, communities, and the food and housing industries.
- Policy examples: taxing unhealthy foods, public health campaigns encouraging exercise and healthy living.
- In a context of shrinking populations, reducing inequality also increases economic sense by enabling fuller contribution from all people.
Boosting employment
- Labor-force patterns and problems:
- "Nearly 90 percent of Europeans in their late 40s are in the labor force. But workforce participation falls below half by people’s early 60s, even as people are living longer and therefore spending more."
- Raising the state retirement age helps public finances but "does little to help individuals keep working longer."
- Evidence on health and employment:
- Someone diagnosed with cardiovascular disease at age 50 is "11 times more likely to leave employment in the United Kingdom."
- A "20 percent reduction in the incidence of six major chronic diseases increases GDP 1 percent within five years and 1.5 percent in ten years," with the effect most pronounced for workers ages 50 to 64 (evidence for the UK).
- Policy measures to boost work at older ages:
- Broader policies across ages focusing on health, skills, and creation of age-friendly jobs (flexible hours, fewer physical demands, greater autonomy).
- Reskilling and support for transitions into new occupations throughout life.
- Anti-age-discrimination laws.
- Such policies both increase employment and raise the effectiveness and fairness of raising the state retirement age.
Policy implications and conclusion: Demography isn’t destiny
- Summary position:
- Failure to adapt risks outliving our health, wealth, relationships, and sense of purpose.
- How we age can be influenced by individual actions and government policies.
- The three-dimensional "longevity dividend":
- Deliver "longer, healthier, and more productive lives" by making adaptation to longer lives an urgent priority.
- Core actionable priorities:
- Redesign health systems toward prevention and life-course interventions.
- Invest in later-life human and social capital, including skills and digital literacy.
- Finance prevention through innovative instruments where necessary.
- Deploy technology (robotics, AI, genomics) alongside cross-sector policies (taxes on unhealthy foods, public health campaigns, anti-inequality measures).
- Reform labor-market policies to create age-friendly jobs, enable reskilling, and enforce anti-age-discrimination protections.
Source: "The Longevity Dividend." F&D Magazine. ANDREW SCOTT, PETER PIOT. June 2025.
Content in this bundle
- The Longevity Dividend